Skip to main content
Michael Robinson, MD, Endocrinology, Redondo Beach, CA, Providence Little Company of Mary Medical Center - Torrance

MichaelFRobinsonMDCPI

Endocrinology Redondo Beach, CA

Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid

Director, Marina Diabetes Center

Dr. Robinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Robinson's full profile

Already have an account?

Summary

  • Michael F. Robinson, M.D., CPI

    Dr. Michael Robinson is a physician specialist in Endocrinology, Diabetes, and Metabolism with over 35 years of experience as a clinician and research clinical investigator. Dr. Robinson is a graduate of The Ohio State University, College of Biological Sciences in Columbus, Ohio and received his M.D. degree from the University of North Carolina at Chapel Hill. He did his medical internship at Ohio State University and a medical residency at Wayne State University in Detroit, Michigan following military service as a Captain in the United States Army Medical Corps. He later completed his Fellowship in Endocrinology and Metabolism at the Mayo Clinic and Mayo Graduate School of Medicine in Rochester, Minnesota where he was also a Mayo Foundation research fellow in bone and mineral metabolism. He has served as Assistant Clinical Professor of Medicine and Clinical Attending Physician at UCLA School of Medicine and has been a Director of community Diabetes and Osteoporosis programs in the Greater Los Angeles area. He is a member of numerous professional organizations including the Endocrine Society, the American Thyroid Association (ATA), the American Association of Clinical Endocrinologists (AACE), the American College of Physicians, the American Academy of Pharmaceutical Physicians (AAPP), and the Association of Clinical Research Professionals.
    Dr. Robinson has published in major medical peer reviewed journals, and is a Certified Physician Investigator (CPI) and Diplomate of the American Board of Internal Medicine. He is currently an attending staff physician at Marina Del Rey Hospital, Little Company of Mary Hospital, Torrance Memorial Hospital, and Centinela Hospital Medical Center. He is Director of the Marina Diabetes Center.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 1977 - 1979
  • Ohio State University Hospital
    Ohio State University HospitalInternship, Internal Medicine, 1973 - 1974
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2025
  • MN State Medical License
    MN State Medical License 1979 - 1987
  • NC State Medical License
    NC State Medical License 1973 - 1986
  • OH State Medical License
    OH State Medical License 1977 - 1979
  • American Board of Internal Medicine Internal Medicine
  • AAPPCertified Physician Investigator
  • American Diabetes AssociationCertificate of Recognition for Diabetes Education

Awards, Honors, & Recognition

  • Medical Advisory Board Doximity, 2023

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Novel Variation in the BSCL-2 Gene in Congenital Lipodystrophy  
    R. Turner, J. Polanco, M. Pietruszka, S. Tayefeh, Y. Valles-Ayoub and M. Robinson, Molecular Biology, 5/31/2021
  • Cimetidine Treatment of Azotemic Secondary Hyperparathyroidism  
    MICHAEL F. ROBINSON, WILLIAM J. JOHNSON, HUNTER HEATH, The Journal of Clinical Endocrinology & Metabolism, Volume 54, Issue 6, 1 June 1982, Pages 1206–1209
  • Impact of CYP2D6 Ultra Rapid Metabolism on Therapeutic Drug Efficacy in Type 2 Diabetic Patients  
    A Pineda, N Williams, N Chaudhry, M Pietruszka, K Daldalyan, Y Valles-Ayoub, M Robinson, J Genet Cell Biol , , Volume: 3, Issue: 3, 5/2020
  • Join now to see all

Professional Memberships

Hospital Affiliations